Colorectal cancer (CRC) is the third most commonly diagnosed cancer globally and the
second cancer in terms of mortality. The prevalence of sarcopenia in patients with CRC …

Simple Summary In its early stages, colorectal cancer (CRC) is a localized tumor, but when it
metastasizes, it has dramatic consequences. Murine models in CRC research are important …

In recent years, rheological measurements of cells and tissues at physiological and
pathological stages have become an essential method to determine how forces and …

Photo-immunotherapy is a promising strategy for the treatment of malignancies; however, its
efficacy is often limited by the low tumor immunogenicity and immunosuppressive tumor …

Liver is the most common site of colorectal cancer (CRC) metastases. Treatment of CRC
liver metastases (CRLM) includes different strategies, prevalently based on the clinical and …

Colorectal cancer (CRC) is a highly malignant tumor associated with poor prognosis, yet the
molecular mechanisms are not fully understood. In this study, we showed that LYAR, a …

The targeted delivery of anti-cancer drugs and isotopes is one of the most pursued goals in
anti-cancer therapy. One of the prime examples of such an application is the intra-arterial …

Simple Summary Metastatic pancreatic ductal adenocarcinoma (mPDAC) has a dismal
prognosis. In selected patients with limited metastatic disease, locoregional therapy, in …

Background The prognosis for patients with colorectal-cancer liver metastases (CRLM) after
curative surgery remains poor and shows great heterogeneity. Early recurrence, defined as …

BACKGROUND Surgical resection is considered the standard treatment option for long-term
survival in colorectal cancer liver metastasis (CRLM) patients, but only a small number of …